NCT00402662View on ClinicalTrials.gov

A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Metastatic Melanoma
Interventions
DRUG

everolimus

DRUG

Imatinib

Trial Locations (1)

06520-8028

Yale Comprehensive Cancer Center at Yale University School of Medicine, New Haven

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Yale University

OTHER